These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34386335)
1. Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335 [TBL] [Abstract][Full Text] [Related]
2. Enhanced Tumor-Specific Disulfiram Chemotherapy by Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050 [TBL] [Abstract][Full Text] [Related]
3. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy. Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225 [TBL] [Abstract][Full Text] [Related]
4. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation. Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072 [TBL] [Abstract][Full Text] [Related]
5. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification. Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734 [TBL] [Abstract][Full Text] [Related]
6. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow. Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100 [TBL] [Abstract][Full Text] [Related]
7. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy. Lan QH; Du CC; Yu RJ; Zhai J; Shi Y; Kou L; Xiao J; Lu CT; Zhao YZ; Yao Q Int J Pharm; 2021 Sep; 607():120978. PubMed ID: 34371152 [TBL] [Abstract][Full Text] [Related]
8. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy. Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206 [TBL] [Abstract][Full Text] [Related]
9. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers. Chen W; Yang W; Chen P; Huang Y; Li F ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340 [TBL] [Abstract][Full Text] [Related]
10. Engineering of a double targeting nanoplatform to elevate ROS generation and DSF anticancer activity. Li W; Huang H; Yao S; Zhao Y; Liu M; Liu X; Guo H J Mater Chem B; 2024 Jul; 12(29):7143-7152. PubMed ID: 38904428 [TBL] [Abstract][Full Text] [Related]
11. Combination of Disulfiram and Copper-Cysteamine Nanoparticles for an Enhanced Antitumor Effect on Esophageal Cancer. Chang Y; Wu F; Pandey NK; Chudal L; Xing M; Zhang X; Nguyen L; Liu X; Liu JP; Chen W; Pan Z ACS Appl Bio Mater; 2020 Oct; 3(10):7147-7157. PubMed ID: 34179726 [TBL] [Abstract][Full Text] [Related]
12. DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis. Li C; Zhou S; Chen C; Zhu L; Li S; Song Z; Liang J; Tang C; Xu N; Liu T; Liu S Colloids Surf B Biointerfaces; 2023 May; 225():113253. PubMed ID: 36934611 [TBL] [Abstract][Full Text] [Related]
13. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting. Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459 [TBL] [Abstract][Full Text] [Related]
14. Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO Cheng FT; Geng YD; Liu YX; Nie X; Zhang XG; Chen ZL; Tang LQ; Wang LH; You YZ; Zhang L Nanoscale Adv; 2023 Jun; 5(12):3336-3347. PubMed ID: 37325521 [TBL] [Abstract][Full Text] [Related]
15. A CD44-targeted Cu(ii) delivery 2D nanoplatform for sensitized disulfiram chemotherapy to triple-negative breast cancer. Gao Z; Li Y; Zhang Y; An P; Chen F; Chen J; You C; Wang Z; Sun B Nanoscale; 2020 Apr; 12(15):8139-8146. PubMed ID: 32236229 [TBL] [Abstract][Full Text] [Related]
16. Self-supplying Cu Gao Y; Cai X; Zou W; Tang X; Jiang L; Hao J; Zheng Y; Ye X; Ying T; Li A RSC Adv; 2024 Apr; 14(19):13180-13189. PubMed ID: 38655468 [TBL] [Abstract][Full Text] [Related]
17. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc. Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421 [TBL] [Abstract][Full Text] [Related]
18. Disulfiram-loaded hollow copper sulfide nanoparticles show anti-tumor effects in preclinical models of colorectal cancer. Jiapaer Z; Zhang L; Ma W; Liu H; Li C; Huang W; Shao S Biochem Biophys Res Commun; 2022 Dec; 635():291-298. PubMed ID: 36327916 [TBL] [Abstract][Full Text] [Related]
19. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy. Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355 [TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents. Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]